NCBS Home page
Accession List
Pathway List
Search
Authorized Users
Help
News archives

Enter a Search String

Special character and space not allowed in the query term. Search string should be at least 2 characters long.
Search in: Search for Match By

 
Result: 1 - 20 of 29 rows are displayed Previous of 2  Next

Reaction List for Accession fig3_CaMKII (Accession Number 2)

Entries are grouped according to Pathway Number and they are alternately color coded using  and  color.
Further ordering can be done to the table header.  indicates that ordering is done according to ascending or descending order.
Keq is calculated only for first order reactions.
Kd is calculated only for second order reactions. [nA+nB <->nC or nA<->nC+nD, where n is number and A,B,C,D are molecules]
  Reaction
Name		Pathway Name / 
Pathway No.		KfKbKdtauReagents
1 CaMKII-bind-CaMCaMKII

Pathway No. 13		49.9998
(uM^-1 s^-1)		5
(s^-1)		Kd(bf) = 0.1(uM)-  Substrate:
 CaM-Ca4
 CaMKII

 Products:
 CaMKII-CaM
2 
  • CaMK-thr286-bind
    -CaM
    		• CaMKII

    Pathway No. 13    		1000.2
    (uM^-1 s^-1)    		0.1
    (s^-1)    		Kd(bf) = 0.0001(uM)-  Substrate:
     CaMKII-thr286
     CaM-Ca4

     Products:
  •  CaMKII-thr286*-C
    aM
    • 3 basal-activityCaMKII

    Pathway No. 13    		0.003
    (s^-1)    		0
    (s^-1)    		--  Substrate:
     CaMKII

     Products:
     CaMKII-thr286
    4 CaM-TR2-bind-CaCaM

    Pathway No. 14    		72
    (uM^-2 s^-1)    		72
    (s^-1)    		Kd(af) = 1(uM)-  Substrate:
     CaM
     Ca
     Ca

     Products:
     CaM-TR2-Ca2
    5 
  • CaM-TR2-Ca2-bind
    -Ca
    		• CaM

    Pathway No. 14    		3.6
    (uM^-1 s^-1)    		10
    (s^-1)    		Kd(bf) = 2.7778(uM)-  Substrate:
     CaM-TR2-Ca2
     Ca

     Products:
     CaM-Ca3
    6 CaM-Ca3-bind-CaCaM

    Pathway No. 14    		0.465
    (uM^-1 s^-1)    		10
    (s^-1)    		Kd(bf) = 21.5054(uM)-  Substrate:
     CaM-Ca3
     Ca

     Products:
     CaM-Ca4
    7 
  • neurogranin-bind
    -CaM
    		• CaM

    Pathway No. 14    		0.3
    (uM^-1 s^-1)    		1
    (s^-1)    		Kd(bf) = 3.3333(uM)-  Substrate:
     neurogranin
     CaM

     Products:
     neurogranin-CaM
    8 
  • dephosph-neurogr
    anin
    		• CaM

    Pathway No. 14    		0.005
    (s^-1)    		0
    (s^-1)    		--  Substrate:
     neurogranin*

     Products:
     neurogranin
    9 Inact-PP1PP1

    Pathway No. 15    		499.98
    (uM^-1 s^-1)    		0.1
    (s^-1)    		Kd(bf) = 0.0002(uM)-  Substrate:
     I1*
     PP1-active

     Products:
     PP1-I1*
    10 dissoc-PP1-I1PP1

    Pathway No. 15    		1
    (s^-1)    		0
    (uM^-1 s^-1)    		--  Substrate:
     PP1-I1

     Products:
     PP1-active
     I1
    11 
  • Ca-bind-CaNAB-Ca
    2
    		• PP2B

    Pathway No. 16    		3.6
    (uM^-2 s^-1)    		1
    (s^-1)    		Kd(af) = 0.527(uM)-  Substrate:
     Ca
     Ca
     CaNAB-Ca2

     Products:
     CaNAB-Ca4
    12 Ca-bind-CaNABPP2B

    Pathway No. 16    		10008
    (uM^-2 s^-1)    		1
    (s^-1)    		Kd(af) = 0.01(uM)-  Substrate:
     CaNAB
     Ca
     Ca

     Products:
     CaNAB-Ca2
    13 
  • CaM-Ca2-bind-CaN
    AB
    		• PP2B

    Pathway No. 16    		0.24
    (uM^-1 s^-1)    		1
    (s^-1)    		Kd(bf) = 4.1667(uM)-  Substrate:
     CaNAB-Ca4
     CaM-TR2-Ca2

     Products:
     CaMCa2-CANAB
    14 
  • CaMCa3-bind-CaNA
    B
    		• PP2B

    Pathway No. 16    		2.238
    (uM^-1 s^-1)    		1
    (s^-1)    		Kd(bf) = 0.4468(uM)-  Substrate:
     CaM-Ca3
     CaNAB-Ca4

     Products:
     CaMCa3-CaNAB
    15 
  • CaMCa4-bind-CaNA
    B
    		• PP2B

    Pathway No. 16    		600
    (uM^-1 s^-1)    		1
    (s^-1)    		Kd(bf) = 0.0017(uM)-  Substrate:
     CaM-Ca4
     CaNAB-Ca4

     Products:
     CaMCa4-CaNAB
    16 
  • cAMP-bind-site-B
    1
    		• PKA

    Pathway No. 17    		54
    (uM^-1 s^-1)    		33
    (s^-1)    		Kd(bf) = 0.6111(uM)-  Substrate:
     R2C2
     cAMP

     Products:
     R2C2-cAMP
     Kf = 54 /sec/uM, Kb = 33 /sec; PKA in normal human T lymphocytes. Hasler et al (1992) FASEB J 6:2735-2741
    Kd =1e-07 M for type II, 5.6e-08 M for type I; Stephen B. Smith et al (1981) PNAS, USA 78: 1591-1595
    Ka1 = 2.1e+07 /M which gives Kd = 47 nM, Kan = 5e+08 /M or Kd of 2nM from Fig.7
    17 
  • cAMP-bind-site-B
    2
    		• PKA

    Pathway No. 17    		54
    (uM^-1 s^-1)    		33
    (s^-1)    		Kd(bf) = 0.6111(uM)-  Substrate:
     R2C2-cAMP
     cAMP

     Products:
     R2C2-cAMP2
     Kf = 54 /sec/uM, Kb = 33 /sec; Same Km (1e-07M) assumed as site B1.
    kf/kb = 0.7e-07M*1e06/(6e05^02) = 2e-13:2.77e-12
    18 
  • cAMP-bind-site-A
    1
    		• PKA

    Pathway No. 17    		75
    (uM^-1 s^-1)    		110
    (s^-1)    		Kd(bf) = 1.4667(uM)-  Substrate:
     R2C2-cAMP2
     cAMP

     Products:
     R2C2-cAMP3
     Kf = 75 /sec/uM, Kb = 110 /sec; This site has higher Kd for cAMP (kinetics within bovine myocardium)
    Dagfinn Ogreid and Stein Ove Doskeland (1981) FEBS Lett. 129(2):287-292
    19 
  • cAMP-bind-site-A
    2
    		• PKA

    Pathway No. 17    		75
    (uM^-1 s^-1)    		32.5
    (s^-1)    		Kd(bf) = 0.4333(uM)-  Substrate:
     cAMP
     R2C2-cAMP3

     Products:
     R2C2-cAMP4
     Now cAMP shows effects of cooperativity and PKA has a low Kd for cAMP.
    20 Release-C1PKA

    Pathway No. 17    		60
    (s^-1)    		18
    (uM^-1 s^-1)    		Kd(cb) = 0.3(uM)-  Substrate:
     R2C2-cAMP4

     Products:
     PKA-active
     R2C-cAMP4
     The complex starts to dissociate and release catalytic subunit C. This has to be fast, as the activation of PKA by cAMP is also fast.
     
    Result: 1 - 20 of 29 rows are displayed Previous of 2  Next


    Database compilation and code copyright (C) 2022, Upinder S. Bhalla and NCBS/TIFR
    This Copyright is applied to ensure that the contents of this database remain freely available. Please see FAQ for details.